TriSalus Life Sciences (TLSI) News Today → Trump just won 2024 (From Porter & Company) (Ad) Free TLSI Stock Alerts $9.31 -0.05 (-0.53%) (As of 04/30/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiativesbusinesswire.com - April 30 at 4:35 PMTriSalus Life Sciences Incmorningstar.com - April 5 at 3:26 PMTriSalus Life Sciences Stock (NASDAQ:TLSI), Earnings Estimates, EPS, and Revenuebenzinga.com - April 3 at 3:30 PMTriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2023 Earnings Call Transcriptinsidermonkey.com - April 2 at 3:10 PMTriSalus Life Sciences, Inc. Q4 sales increasemarkets.businessinsider.com - April 1 at 10:44 AMTriSalus Reports Q4 and Full Year 2023 Financial Results and Business Updatefinance.yahoo.com - April 1 at 10:44 AMTriSalus Life Sciences Inc (TLSI) Q4 and Full Year 2023 Earnings: Revenue Growth Amidst Late ...finance.yahoo.com - April 1 at 10:44 AMTriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meetingfinance.yahoo.com - March 26 at 12:21 PMTriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meetingfinance.yahoo.com - March 21 at 11:51 AMTriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Resultsbusinesswire.com - March 11 at 5:15 PMTriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for "Nelitolimod" as the Nonproprietary Drug Name for SD-101finance.yahoo.com - March 7 at 10:38 AMTriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association's Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101businesswire.com - March 7 at 7:00 AMTriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumorsbusinesswire.com - February 29 at 7:00 AMTriSalus Life Sciences: Rocket-Like Recovery Could Be An Inflection Pointseekingalpha.com - January 24 at 11:57 PMTriSalus Life Sciences Inc TLSImorningstar.com - January 9 at 1:10 PMMaxim Group Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)markets.businessinsider.com - December 17 at 7:07 PMTriSalus Life Sciences files to sell 5.9 million shares for holdersmsn.com - December 15 at 5:31 PMMyomo, Aileron Therapeutics among healthcare moversmsn.com - December 15 at 12:31 PMTriSalus Life Sciences Inc Reports Revenue Growth and Clinical Advancements in Q3 2023finance.yahoo.com - December 13 at 4:43 PMmarketbeat.com - December 11 at 12:08 PMmarketbeat.com - August 18 at 9:46 AMmarketbeat.com - August 11 at 11:44 AMmarketbeat.com - August 11 at 10:19 AMmarketbeat.com - August 11 at 10:10 AMmarketbeat.com - August 11 at 9:58 AMmarketbeat.com - August 11 at 9:36 AM Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address #1 election stock (Ad)I’ve found the number one company to buy… Before either Trump or Biden wins in November. It all has to do with an overlooked executive order that Trump signed just days before leaving office… and that Biden has quietly hijacked for his own political power. For the full story, click here. TLSI Media Mentions By Week TLSI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLSI News Sentiment▼0.000.34▲Average Medical News Sentiment TLSI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLSI Articles This Week▼10▲TLSI Articles Average Week Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AngioDynamics News Today Sight Sciences News Today Utah Medical Products News Today Pulmonx News Today Inovio Pharmaceuticals News Today AVITA Medical News Today Cerus News Today Accuray News Today CVRx News Today Lyra Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TLSI) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTracker#1 election stockPorter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBiden out June 13; Kamala won’t replace him?Paradigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
